These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 788989)

  • 21. Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new "loop" diuretic.
    Flamenbaum W; Friedman R
    Pharmacotherapy; 1982; 2(4):213-22. PubMed ID: 6763204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.
    Friedman PA; Roch-Ramel F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):82-91. PubMed ID: 909060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diuretic evaluation of bumetanide (author's transl)].
    Barrientos Guzmán A; Ortuño de Solo MT
    Med Clin (Barc); 1979 Nov; 73(8):338-41. PubMed ID: 522529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of the endocochlear potential by the new "loop" diuretic, bumetanide.
    Kusakari J; Kambayashi J; Ise I; Kawamoto K
    Acta Otolaryngol; 1978; 86(5-6):336-41. PubMed ID: 716856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, placebo-controlled study of loop diuretics in patients with essential hypertension: the bumetanide and furosemide on lipid profile (BUFUL) clinical study report.
    van der Heijden M; Donders SH; Cleophas TJ; Niemeyer MG; van der Meulen J; Bernink PJ; de Planque BA; van der Wall EE
    J Clin Pharmacol; 1998 Jul; 38(7):630-5. PubMed ID: 9702848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of bumetanide on renal function and blood composition in sheep.
    Pickering EC; Williams JH; Ergene N
    Res Vet Sci; 1976 Nov; 21(3):259-63. PubMed ID: 1030818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bumetanide stimulation of sodium permeability of the apical membrane of toad urinary bladder.
    Li JH; Kau ST
    J Pharmacol Exp Ther; 1988 Sep; 246(3):980-5. PubMed ID: 2843638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some aspects of the renal action and clinical pharmacology of oral bumetanide in man.
    Bourke E
    Postgrad Med J; 1975; 51 Suppl 6():23-26. PubMed ID: 1105529
    [No Abstract]   [Full Text] [Related]  

  • 29. Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs.
    Hannaert P; Alvarez-Guerra M; Pirot D; Nazaret C; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):193-9. PubMed ID: 11882915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of loop diuretics: a comparative study.
    Ansuini R; Pulido M; Pupita G; Gaggi S; Pupita F
    Int J Clin Pharmacol Res; 1985; 5(2):113-21. PubMed ID: 4018941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
    Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
    Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal electrolyte excretion pattern in response to bumetanide in healthy volunteers.
    Hutcheon DE; Vincent ME; Sandhu RS
    J Clin Pharmacol; 1981; 21(11):604-9. PubMed ID: 7338570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease of ischemic injury to the isolated perfused rat liver by loop diuretics.
    Fiegen RJ; Rauen U; Hartmann M; Decking UK; de Groot H
    Hepatology; 1997 Jun; 25(6):1425-31. PubMed ID: 9185763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cochlear N1 depression produced by the new "loop" diuretic, bumetanide, in cats.
    Brown RD
    Neuropharmacology; 1975 Aug; 14(8):547-53. PubMed ID: 1178111
    [No Abstract]   [Full Text] [Related]  

  • 35. Loop diuretics.
    Greger R; Wangemann P
    Ren Physiol; 1987; 10(3-4):174-83. PubMed ID: 3330836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the sites and mechanisms of action of bumetanide in man.
    Jayakumar S; Puschett JB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):251-8. PubMed ID: 850144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal effects of bumetanide.
    Higashio T; Abe Y; Yamamoto K
    J Pharmacol Exp Ther; 1978 Oct; 207(1):212-20. PubMed ID: 702342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diuretics].
    Schwartz J; Bloch R; Imbs JL; Spach MO
    Pathol Biol (Paris); 1986 Sep; 34(7):861-85. PubMed ID: 3537932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of ethacrynic acid, bumetanide, frusemide, spironolactone and ADH on electrolyte excretion in ponies.
    Alexander F
    J Vet Pharmacol Ther; 1982 Sep; 5(3):153-60. PubMed ID: 7143552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mineral excretion following furosemide compared with bumetanide therapy in premature infants.
    Shankaran S; Liang KC; Ilagan N; Fleischmann L
    Pediatr Nephrol; 1995 Apr; 9(2):159-62. PubMed ID: 7794709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.